JP2009538877A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009538877A5 JP2009538877A5 JP2009512585A JP2009512585A JP2009538877A5 JP 2009538877 A5 JP2009538877 A5 JP 2009538877A5 JP 2009512585 A JP2009512585 A JP 2009512585A JP 2009512585 A JP2009512585 A JP 2009512585A JP 2009538877 A5 JP2009538877 A5 JP 2009538877A5
- Authority
- JP
- Japan
- Prior art keywords
- triazolo
- pyrazin
- pyrazol
- piperazin
- ylamino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 150000001875 compounds Chemical class 0.000 claims description 45
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims description 4
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 claims description 3
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 3
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 3
- 125000000217 alkyl group Chemical group 0.000 claims 15
- 125000000753 cycloalkyl group Chemical group 0.000 claims 9
- 229910052739 hydrogen Inorganic materials 0.000 claims 6
- 239000001257 hydrogen Substances 0.000 claims 6
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 6
- -1 2-morpholin-4-yl-ethoxy Chemical group 0.000 claims 5
- 125000003118 aryl group Chemical group 0.000 claims 5
- 125000001072 heteroaryl group Chemical group 0.000 claims 5
- 125000001475 halogen functional group Chemical group 0.000 claims 4
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 3
- 125000004076 pyridyl group Chemical group 0.000 claims 3
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 claims 2
- CHQJJYPKXYBSSN-UHFFFAOYSA-N N-[4-(4-tert-butylpiperazin-1-yl)phenyl]-5-(1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyrazin-8-amine Chemical compound C1CN(C(C)(C)C)CCN1C(C=C1)=CC=C1NC(C1=NC=NN11)=NC=C1C1=CNN=C1 CHQJJYPKXYBSSN-UHFFFAOYSA-N 0.000 claims 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 claims 2
- 125000003545 alkoxy group Chemical group 0.000 claims 2
- 125000004103 aminoalkyl group Chemical group 0.000 claims 2
- 125000003710 aryl alkyl group Chemical group 0.000 claims 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 125000004446 heteroarylalkyl group Chemical group 0.000 claims 2
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims 2
- 230000000155 isotopic effect Effects 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 239000000651 prodrug Substances 0.000 claims 2
- 229940002612 prodrug Drugs 0.000 claims 2
- 150000003230 pyrimidines Chemical class 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 239000012453 solvate Substances 0.000 claims 2
- DXISVZIQEPORSC-UHFFFAOYSA-N (4-butan-2-ylpiperazin-1-yl)-[4-[[5-(1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyrazin-8-yl]amino]phenyl]methanone Chemical compound C1CN(C(C)CC)CCN1C(=O)C(C=C1)=CC=C1NC(C1=NC=NN11)=NC=C1C1=CNN=C1 DXISVZIQEPORSC-UHFFFAOYSA-N 0.000 claims 1
- VBVSWIUDHKAUIO-UHFFFAOYSA-N (4-ethylpiperazin-1-yl)-[4-[[5-(1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyrazin-8-yl]amino]phenyl]methanone Chemical compound C1CN(CC)CCN1C(=O)C(C=C1)=CC=C1NC(C1=NC=NN11)=NC=C1C1=CNN=C1 VBVSWIUDHKAUIO-UHFFFAOYSA-N 0.000 claims 1
- AGRRXZLTXIRFHF-UHFFFAOYSA-N (4-phenylpiperazin-1-yl)-[4-[[5-(1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyrazin-8-yl]amino]phenyl]methanone Chemical compound C=1C=C(NC=2C3=NC=NN3C(C3=CNN=C3)=CN=2)C=CC=1C(=O)N(CC1)CCN1C1=CC=CC=C1 AGRRXZLTXIRFHF-UHFFFAOYSA-N 0.000 claims 1
- XSDUUIHPTXGMTN-UHFFFAOYSA-N (4-propan-2-ylpiperazin-1-yl)-[3-[[5-(1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyrazin-8-yl]amino]phenyl]methanone Chemical compound C1CN(C(C)C)CCN1C(=O)C1=CC=CC(NC=2C3=NC=NN3C(C3=CNN=C3)=CN=2)=C1 XSDUUIHPTXGMTN-UHFFFAOYSA-N 0.000 claims 1
- FFFUXLUPRZEMIL-UHFFFAOYSA-N 1-[4-[[5-(1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyrazin-8-yl]amino]phenyl]piperazin-2-one Chemical compound O=C1CNCCN1C(C=C1)=CC=C1NC(C1=NC=NN11)=NC=C1C1=CNN=C1 FFFUXLUPRZEMIL-UHFFFAOYSA-N 0.000 claims 1
- QDKZNYZQKYAEMW-UHFFFAOYSA-N 1-[5-[8-(4-morpholin-4-ylanilino)-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]thiophen-2-yl]ethanone Chemical compound S1C(C(=O)C)=CC=C1C(N1N=CN=C11)=CN=C1NC1=CC=C(N2CCOCC2)C=C1 QDKZNYZQKYAEMW-UHFFFAOYSA-N 0.000 claims 1
- KAESVJOAVNADME-UHFFFAOYSA-N 1H-pyrrole Natural products C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 claims 1
- YBUAZHKDDGUHHM-UHFFFAOYSA-N 2,5-dihydropyrrol-1-yl-[4-[[5-(1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyrazin-8-yl]amino]phenyl]methanone Chemical compound C=1C=C(NC=2C3=NC=NN3C(C3=CNN=C3)=CN=2)C=CC=1C(=O)N1CC=CC1 YBUAZHKDDGUHHM-UHFFFAOYSA-N 0.000 claims 1
- HRPXCAHEPGIUMW-UHFFFAOYSA-N 2,6-difluoro-4-[8-(4-morpholin-4-ylanilino)-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]benzamide Chemical compound C1=C(F)C(C(=O)N)=C(F)C=C1C(N1N=CN=C11)=CN=C1NC1=CC=C(N2CCOCC2)C=C1 HRPXCAHEPGIUMW-UHFFFAOYSA-N 0.000 claims 1
- YLMHOHHWOPOHBH-UHFFFAOYSA-N 2,6-difluoro-4-[8-[4-(4-propan-2-ylpiperazin-1-yl)anilino]-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]benzamide Chemical compound C1CN(C(C)C)CCN1C(C=C1)=CC=C1NC(C1=NC=NN11)=NC=C1C1=CC(F)=C(C(N)=O)C(F)=C1 YLMHOHHWOPOHBH-UHFFFAOYSA-N 0.000 claims 1
- BFSRNZLXCZKVNW-UHFFFAOYSA-N 2-[8-(4-morpholin-4-ylanilino)-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]-4,5-dihydrothieno[2,3-c]pyrrol-6-one Chemical compound S1C=2C(=O)NCC=2C=C1C(N1N=CN=C11)=CN=C1NC(C=C1)=CC=C1N1CCOCC1 BFSRNZLXCZKVNW-UHFFFAOYSA-N 0.000 claims 1
- CGZZIEITQLQBOG-UHFFFAOYSA-N 2-[8-(4-morpholin-4-ylanilino)-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]-5,6-dihydrofuro[2,3-c]pyrrol-4-one Chemical compound C=1C=2C(=O)NCC=2OC=1C(N1N=CN=C11)=CN=C1NC(C=C1)=CC=C1N1CCOCC1 CGZZIEITQLQBOG-UHFFFAOYSA-N 0.000 claims 1
- VKUVJWJZEWKBRP-UHFFFAOYSA-N 2-fluoro-4-[8-(4-morpholin-4-ylanilino)-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]benzamide Chemical compound C1=C(F)C(C(=O)N)=CC=C1C(N1N=CN=C11)=CN=C1NC1=CC=C(N2CCOCC2)C=C1 VKUVJWJZEWKBRP-UHFFFAOYSA-N 0.000 claims 1
- BNNUKUVBEFWNMO-UHFFFAOYSA-N 2-fluoro-4-[8-[4-(4-methylpiperazin-1-yl)anilino]-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]benzamide Chemical compound C1CN(C)CCN1C(C=C1)=CC=C1NC(C1=NC=NN11)=NC=C1C1=CC=C(C(N)=O)C(F)=C1 BNNUKUVBEFWNMO-UHFFFAOYSA-N 0.000 claims 1
- VBVIHCRFIFYNSO-UHFFFAOYSA-N 2-methoxy-N-[(6-methylpyridin-3-yl)methyl]-4-[[5-(1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyrazin-8-yl]amino]benzamide Chemical compound C=1C=C(C(=O)NCC=2C=NC(C)=CC=2)C(OC)=CC=1NC(C1=NC=NN11)=NC=C1C=1C=NNC=1 VBVIHCRFIFYNSO-UHFFFAOYSA-N 0.000 claims 1
- GIAQJIIDNXNNSY-UHFFFAOYSA-N 3,3-dimethyl-5-[8-[4-(4-propan-2-ylpiperazin-1-yl)anilino]-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]-2h-isoindol-1-one Chemical compound C1CN(C(C)C)CCN1C(C=C1)=CC=C1NC(C1=NC=NN11)=NC=C1C1=CC=C(C(=O)NC2(C)C)C2=C1 GIAQJIIDNXNNSY-UHFFFAOYSA-N 0.000 claims 1
- QVDSFKDOVDIPSJ-UHFFFAOYSA-N 3,6-dihydro-2H-pyridin-1-yl-[4-[[5-(1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyrazin-8-yl]amino]phenyl]methanone Chemical compound C=1C=C(NC=2C3=NC=NN3C(C3=CNN=C3)=CN=2)C=CC=1C(=O)N1CCC=CC1 QVDSFKDOVDIPSJ-UHFFFAOYSA-N 0.000 claims 1
- ZIJWGGAFCXAOPN-UHFFFAOYSA-N 3-[4-[8-(4-morpholin-4-ylanilino)-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]phenyl]-4,5-dihydro-1h-pyridazin-6-one Chemical compound N1C(=O)CCC(C=2C=CC(=CC=2)C=2N3N=CN=C3C(NC=3C=CC(=CC=3)N3CCOCC3)=NC=2)=N1 ZIJWGGAFCXAOPN-UHFFFAOYSA-N 0.000 claims 1
- MMPDHCPOSYHTSV-UHFFFAOYSA-N 3-[8-(4-morpholin-4-ylanilino)-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]-1-benzothiophene-7-carboxylic acid Chemical compound C=1SC=2C(C(=O)O)=CC=CC=2C=1C(N1N=CN=C11)=CN=C1NC(C=C1)=CC=C1N1CCOCC1 MMPDHCPOSYHTSV-UHFFFAOYSA-N 0.000 claims 1
- UXDBSBVOMPXFBF-UHFFFAOYSA-N 3-[8-[4-(4-propan-2-ylpiperazin-1-yl)anilino]-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]-1-benzothiophene-7-carboxamide Chemical compound C1CN(C(C)C)CCN1C(C=C1)=CC=C1NC(C1=NC=NN11)=NC=C1C1=CSC2=C(C(N)=O)C=CC=C12 UXDBSBVOMPXFBF-UHFFFAOYSA-N 0.000 claims 1
- JHOJVWLTDDKOKE-UHFFFAOYSA-N 3-[[5-(1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyrazin-8-yl]amino]-N-(pyridin-2-ylmethyl)benzamide Chemical compound C=1C=CC(NC=2C3=NC=NN3C(C3=CNN=C3)=CN=2)=CC=1C(=O)NCC1=CC=CC=N1 JHOJVWLTDDKOKE-UHFFFAOYSA-N 0.000 claims 1
- GZYQVOQCWOVTBW-UHFFFAOYSA-N 3-[[5-(1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyrazin-8-yl]amino]benzamide Chemical compound NC(=O)C1=CC=CC(NC=2C3=NC=NN3C(C3=CNN=C3)=CN=2)=C1 GZYQVOQCWOVTBW-UHFFFAOYSA-N 0.000 claims 1
- ZSUFWZOCGCTTBU-UHFFFAOYSA-N 3-fluoro-4-[8-(4-morpholin-4-ylanilino)-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]benzamide Chemical compound FC1=CC(C(=O)N)=CC=C1C(N1N=CN=C11)=CN=C1NC1=CC=C(N2CCOCC2)C=C1 ZSUFWZOCGCTTBU-UHFFFAOYSA-N 0.000 claims 1
- ZKIPRFSOFNNCMK-UHFFFAOYSA-N 3-fluoro-4-[8-[4-(4-methylpiperazin-1-yl)anilino]-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]benzamide Chemical compound C1CN(C)CCN1C(C=C1)=CC=C1NC(C1=NC=NN11)=NC=C1C1=CC=C(C(N)=O)C=C1F ZKIPRFSOFNNCMK-UHFFFAOYSA-N 0.000 claims 1
- BUYLMIPFLKSPIS-UHFFFAOYSA-N 4-[4-[8-(4-morpholin-4-ylanilino)-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]phenyl]-1,3-thiazol-2-amine Chemical compound S1C(N)=NC(C=2C=CC(=CC=2)C=2N3N=CN=C3C(NC=3C=CC(=CC=3)N3CCOCC3)=NC=2)=C1 BUYLMIPFLKSPIS-UHFFFAOYSA-N 0.000 claims 1
- QSPAEZUXLKWALT-UHFFFAOYSA-N 4-[8-(4-morpholin-4-ylanilino)-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]-1,3-thiazole-2-carboxamide Chemical compound S1C(C(=O)N)=NC(C=2N3N=CN=C3C(NC=3C=CC(=CC=3)N3CCOCC3)=NC=2)=C1 QSPAEZUXLKWALT-UHFFFAOYSA-N 0.000 claims 1
- IUSQIOFMDVXKRJ-UHFFFAOYSA-N 4-[8-(4-morpholin-4-ylanilino)-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]benzamide Chemical compound C1=CC(C(=O)N)=CC=C1C(N1N=CN=C11)=CN=C1NC1=CC=C(N2CCOCC2)C=C1 IUSQIOFMDVXKRJ-UHFFFAOYSA-N 0.000 claims 1
- FYSTUPGUTFXHBJ-UHFFFAOYSA-N 4-[8-(4-morpholin-4-ylanilino)-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]furan-2-carboxamide Chemical compound O1C(C(=O)N)=CC(C=2N3N=CN=C3C(NC=3C=CC(=CC=3)N3CCOCC3)=NC=2)=C1 FYSTUPGUTFXHBJ-UHFFFAOYSA-N 0.000 claims 1
- SFEDCFUOTZYOEK-UHFFFAOYSA-N 4-[8-(4-morpholin-4-ylanilino)-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]thiophene-2-carboxamide Chemical compound S1C(C(=O)N)=CC(C=2N3N=CN=C3C(NC=3C=CC(=CC=3)N3CCOCC3)=NC=2)=C1 SFEDCFUOTZYOEK-UHFFFAOYSA-N 0.000 claims 1
- WNDKNBCWYSXUPN-UHFFFAOYSA-N 4-[8-(4-piperazin-1-ylanilino)-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]thiophene-2-carboxamide Chemical compound S1C(C(=O)N)=CC(C=2N3N=CN=C3C(NC=3C=CC(=CC=3)N3CCNCC3)=NC=2)=C1 WNDKNBCWYSXUPN-UHFFFAOYSA-N 0.000 claims 1
- JPRCFWLPRKUDRL-UHFFFAOYSA-N 4-[8-[(6-benzamidopyridin-3-yl)amino]-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]thiophene-2-carboxamide Chemical compound S1C(C(=O)N)=CC(C=2N3N=CN=C3C(NC=3C=NC(NC(=O)C=4C=CC=CC=4)=CC=3)=NC=2)=C1 JPRCFWLPRKUDRL-UHFFFAOYSA-N 0.000 claims 1
- ZWOSSIVBFAYQDW-UHFFFAOYSA-N 4-[8-[(6-morpholin-4-ylpyridin-3-yl)amino]-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]furan-2-carboxamide Chemical compound O1C(C(=O)N)=CC(C=2N3N=CN=C3C(NC=3C=NC(=CC=3)N3CCOCC3)=NC=2)=C1 ZWOSSIVBFAYQDW-UHFFFAOYSA-N 0.000 claims 1
- MDGOPRLPIZCNLF-UHFFFAOYSA-N 4-[8-[(6-morpholin-4-ylpyridin-3-yl)amino]-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]thiophene-2-carboxamide Chemical compound S1C(C(=O)N)=CC(C=2N3N=CN=C3C(NC=3C=NC(=CC=3)N3CCOCC3)=NC=2)=C1 MDGOPRLPIZCNLF-UHFFFAOYSA-N 0.000 claims 1
- IMPPWUFSZPGBCS-UHFFFAOYSA-N 4-[8-[3-methoxy-4-[(6-methylpyridin-3-yl)methylcarbamoyl]anilino]-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]thiophene-2-carboxamide Chemical compound C=1C=C(C(=O)NCC=2C=NC(C)=CC=2)C(OC)=CC=1NC(C1=NC=NN11)=NC=C1C1=CSC(C(N)=O)=C1 IMPPWUFSZPGBCS-UHFFFAOYSA-N 0.000 claims 1
- CBDPFOMIDRBHPG-UHFFFAOYSA-N 4-[8-[4-(2-morpholin-4-ylethoxy)anilino]-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]thiophene-2-carboxamide Chemical class S1C(C(=O)N)=CC(C=2N3N=CN=C3C(NC=3C=CC(OCCN4CCOCC4)=CC=3)=NC=2)=C1 CBDPFOMIDRBHPG-UHFFFAOYSA-N 0.000 claims 1
- ULADOTYNHIXXPX-UHFFFAOYSA-N 4-[8-[4-(4-methylpiperazin-1-yl)anilino]-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]-1h-pyridin-2-one Chemical compound C1CN(C)CCN1C(C=C1)=CC=C1NC(C1=NC=NN11)=NC=C1C1=CC(=O)NC=C1 ULADOTYNHIXXPX-UHFFFAOYSA-N 0.000 claims 1
- RPTBHZFWKPSPBV-UHFFFAOYSA-N 4-[8-[4-(4-methylpiperazin-1-yl)anilino]-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]benzamide Chemical compound C1CN(C)CCN1C(C=C1)=CC=C1NC(C1=NC=NN11)=NC=C1C1=CC=C(C(N)=O)C=C1 RPTBHZFWKPSPBV-UHFFFAOYSA-N 0.000 claims 1
- JGGDMMYPOPZHLL-UHFFFAOYSA-N 4-[8-[4-(4-methylpiperazin-1-yl)anilino]-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]thiophene-2-carboxamide Chemical class C1CN(C)CCN1C(C=C1)=CC=C1NC(C1=NC=NN11)=NC=C1C1=CSC(C(N)=O)=C1 JGGDMMYPOPZHLL-UHFFFAOYSA-N 0.000 claims 1
- JQWATXZJZVGVRZ-UHFFFAOYSA-N 4-[8-[4-(4-propan-2-ylpiperazin-1-yl)anilino]-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]-1,3-thiazole-2-carboxamide Chemical class C1CN(C(C)C)CCN1C(C=C1)=CC=C1NC(C1=NC=NN11)=NC=C1C1=CSC(C(N)=O)=N1 JQWATXZJZVGVRZ-UHFFFAOYSA-N 0.000 claims 1
- ZYVZHYOXPSBOIR-UHFFFAOYSA-N 4-[8-[4-(4-propan-2-ylpiperazin-1-yl)anilino]-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]-2,3-dihydroisoindol-1-one Chemical compound C1CN(C(C)C)CCN1C(C=C1)=CC=C1NC(C1=NC=NN11)=NC=C1C1=CC=CC2=C1CNC2=O ZYVZHYOXPSBOIR-UHFFFAOYSA-N 0.000 claims 1
- COGVMNOHISNIOE-UHFFFAOYSA-N 4-[8-[4-(4-propan-2-ylpiperazin-1-yl)anilino]-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]furan-2-carboxamide Chemical class C1CN(C(C)C)CCN1C(C=C1)=CC=C1NC(C1=NC=NN11)=NC=C1C1=COC(C(N)=O)=C1 COGVMNOHISNIOE-UHFFFAOYSA-N 0.000 claims 1
- WZVOWQNLPSCZPI-UHFFFAOYSA-N 4-[8-[4-(4-propan-2-ylpiperazin-1-yl)anilino]-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]thiophene-2-carboxamide Chemical class C1CN(C(C)C)CCN1C(C=C1)=CC=C1NC(C1=NC=NN11)=NC=C1C1=CSC(C(N)=O)=C1 WZVOWQNLPSCZPI-UHFFFAOYSA-N 0.000 claims 1
- HIXXPXGQJXLBEW-UHFFFAOYSA-N 4-[8-[4-(benzylcarbamoyl)-3-methoxyanilino]-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]thiophene-2-carboxamide Chemical compound C=1C=C(C(=O)NCC=2C=CC=CC=2)C(OC)=CC=1NC(C1=NC=NN11)=NC=C1C1=CSC(C(N)=O)=C1 HIXXPXGQJXLBEW-UHFFFAOYSA-N 0.000 claims 1
- IAPMHNPGQOHSOR-OKILXGFUSA-N 4-[8-[4-[(2s,6r)-2,6-dimethylmorpholin-4-yl]anilino]-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]thiophene-2-carboxamide Chemical compound C1[C@@H](C)O[C@@H](C)CN1C(C=C1)=CC=C1NC(C1=NC=NN11)=NC=C1C1=CSC(C(N)=O)=C1 IAPMHNPGQOHSOR-OKILXGFUSA-N 0.000 claims 1
- IIBPKZRWJHPSBG-UHFFFAOYSA-N 4-[8-[4-[1-(2,2,2-trifluoroethyl)piperidin-4-yl]anilino]-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]thiophene-2-carboxamide Chemical compound S1C(C(=O)N)=CC(C=2N3N=CN=C3C(NC=3C=CC(=CC=3)C3CCN(CC(F)(F)F)CC3)=NC=2)=C1 IIBPKZRWJHPSBG-UHFFFAOYSA-N 0.000 claims 1
- SFFPRZBXKZPBER-UHFFFAOYSA-N 4-[8-[4-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]anilino]-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]thiophene-2-carboxamide Chemical compound S1C(C(=O)N)=CC(C=2N3N=CN=C3C(NC=3C=CC(=CC=3)N3CCN(CC(F)(F)F)CC3)=NC=2)=C1 SFFPRZBXKZPBER-UHFFFAOYSA-N 0.000 claims 1
- CEQGCMHVEDNLEF-UHFFFAOYSA-N 4-[8-[4-[4-(cyclopropylmethyl)piperazin-1-yl]anilino]-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]thiophene-2-carboxamide Chemical compound S1C(C(=O)N)=CC(C=2N3N=CN=C3C(NC=3C=CC(=CC=3)N3CCN(CC4CC4)CC3)=NC=2)=C1 CEQGCMHVEDNLEF-UHFFFAOYSA-N 0.000 claims 1
- VLHDUMDOLLDKJW-UHFFFAOYSA-N 4-[8-[[6-(4-propan-2-ylpiperazin-1-yl)pyridin-3-yl]amino]-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]-2,3-dihydroisoindol-1-one Chemical compound C1CN(C(C)C)CCN1C(N=C1)=CC=C1NC(C1=NC=NN11)=NC=C1C1=CC=CC2=C1CNC2=O VLHDUMDOLLDKJW-UHFFFAOYSA-N 0.000 claims 1
- USMICHPAMTWFHL-UHFFFAOYSA-N 4-[8-[[6-(4-propan-2-ylpiperazin-1-yl)pyridin-3-yl]amino]-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]furan-2-carboxamide Chemical compound C1CN(C(C)C)CCN1C(N=C1)=CC=C1NC(C1=NC=NN11)=NC=C1C1=COC(C(N)=O)=C1 USMICHPAMTWFHL-UHFFFAOYSA-N 0.000 claims 1
- DSOIXOVZRRVUOU-UHFFFAOYSA-N 4-[8-[[6-(4-propan-2-ylpiperazin-1-yl)pyridin-3-yl]amino]-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]thiophene-2-carboxamide Chemical compound C1CN(C(C)C)CCN1C(N=C1)=CC=C1NC(C1=NC=NN11)=NC=C1C1=CSC(C(N)=O)=C1 DSOIXOVZRRVUOU-UHFFFAOYSA-N 0.000 claims 1
- NNAAHUUFMAXYRO-UHFFFAOYSA-N 4-[8-[[6-[(2-phenylacetyl)amino]pyridin-3-yl]amino]-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]thiophene-2-carboxamide Chemical compound S1C(C(=O)N)=CC(C=2N3N=CN=C3C(NC=3C=NC(NC(=O)CC=4C=CC=CC=4)=CC=3)=NC=2)=C1 NNAAHUUFMAXYRO-UHFFFAOYSA-N 0.000 claims 1
- AQUIBDVXRAUIFS-UHFFFAOYSA-N 4-[8-[[6-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]pyridin-3-yl]amino]-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]thiophene-2-carboxamide Chemical compound S1C(C(=O)N)=CC(C=2N3N=CN=C3C(NC=3C=NC(=CC=3)N3CCN(CC(F)(F)F)CC3)=NC=2)=C1 AQUIBDVXRAUIFS-UHFFFAOYSA-N 0.000 claims 1
- QBLGZKNTTFTHOK-UHFFFAOYSA-N 4-[8-[[6-[4-(cyclopropylmethyl)piperazin-1-yl]pyridin-3-yl]amino]-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]thiophene-2-carboxamide Chemical compound S1C(C(=O)N)=CC(C=2N3N=CN=C3C(NC=3C=NC(=CC=3)N3CCN(CC4CC4)CC3)=NC=2)=C1 QBLGZKNTTFTHOK-UHFFFAOYSA-N 0.000 claims 1
- BROKFMHCLYAGQE-UHFFFAOYSA-N 4-[[5-(1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyrazin-8-yl]amino]-N-(2-pyridin-4-ylethyl)benzamide Chemical compound C=1C=C(NC=2C3=NC=NN3C(C3=CNN=C3)=CN=2)C=CC=1C(=O)NCCC1=CC=NC=C1 BROKFMHCLYAGQE-UHFFFAOYSA-N 0.000 claims 1
- LCRWIORMRJTMFA-UHFFFAOYSA-N 4-[[5-(1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyrazin-8-yl]amino]-N-(pyridin-3-ylmethyl)benzamide Chemical compound C=1C=C(NC=2C3=NC=NN3C(C3=CNN=C3)=CN=2)C=CC=1C(=O)NCC1=CC=CN=C1 LCRWIORMRJTMFA-UHFFFAOYSA-N 0.000 claims 1
- QTKFTAILYNCRCP-UHFFFAOYSA-N 4-[[5-(2-oxo-1h-pyridin-4-yl)-[1,2,4]triazolo[1,5-a]pyrazin-8-yl]amino]-n-(pyridin-3-ylmethyl)benzamide Chemical compound C=1C=C(NC=2C3=NC=NN3C(C3=CC(=O)NC=C3)=CN=2)C=CC=1C(=O)NCC1=CC=CN=C1 QTKFTAILYNCRCP-UHFFFAOYSA-N 0.000 claims 1
- 125000004203 4-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 125000004195 4-methylpiperazin-1-yl group Chemical group [H]C([H])([H])N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 claims 1
- DEFMVBAGGURMRQ-UHFFFAOYSA-N 5-(1,3-benzothiazol-6-yl)-n-(4-morpholin-4-ylphenyl)-[1,2,4]triazolo[1,5-a]pyrazin-8-amine Chemical compound C1COCCN1C(C=C1)=CC=C1NC(C1=NC=NN11)=NC=C1C1=CC=C(N=CS2)C2=C1 DEFMVBAGGURMRQ-UHFFFAOYSA-N 0.000 claims 1
- KDVFEVNNBOPRSV-UHFFFAOYSA-N 5-(1-benzothiophen-3-yl)-n-(4-morpholin-4-ylphenyl)-[1,2,4]triazolo[1,5-a]pyrazin-8-amine Chemical compound C1COCCN1C(C=C1)=CC=C1NC(C1=NC=NN11)=NC=C1C1=CSC2=CC=CC=C12 KDVFEVNNBOPRSV-UHFFFAOYSA-N 0.000 claims 1
- RAFCCULIVQNLTP-UHFFFAOYSA-N 5-(1-benzothiophen-3-yl)-n-[4-(4-propan-2-ylpiperazin-1-yl)phenyl]-[1,2,4]triazolo[1,5-a]pyrazin-8-amine Chemical compound C1CN(C(C)C)CCN1C(C=C1)=CC=C1NC(C1=NC=NN11)=NC=C1C1=CSC2=CC=CC=C12 RAFCCULIVQNLTP-UHFFFAOYSA-N 0.000 claims 1
- UZTYKKLCZXYXSG-CABCVRRESA-N 5-(1H-pyrazol-4-yl)-N-[4-[(2S,5R)-2,4,5-trimethylpiperazin-1-yl]phenyl]-[1,2,4]triazolo[1,5-a]pyrazin-8-amine Chemical compound C[C@H]1CN(C)[C@H](C)CN1C(C=C1)=CC=C1NC(C1=NC=NN11)=NC=C1C1=CNN=C1 UZTYKKLCZXYXSG-CABCVRRESA-N 0.000 claims 1
- JFHNYCAHTYRRQB-UHFFFAOYSA-N 5-(1H-pyrazol-4-yl)-N-[4-[1-(2,2,2-trifluoroethyl)piperidin-4-yl]phenyl]-[1,2,4]triazolo[1,5-a]pyrazin-8-amine Chemical compound C1CN(CC(F)(F)F)CCC1C(C=C1)=CC=C1NC(C1=NC=NN11)=NC=C1C1=CNN=C1 JFHNYCAHTYRRQB-UHFFFAOYSA-N 0.000 claims 1
- ZZCXQFFNUVXYKY-UHFFFAOYSA-N 5-(1H-pyrazol-4-yl)-N-[4-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]phenyl]-[1,2,4]triazolo[1,5-a]pyrazin-8-amine Chemical compound C1CN(CC(F)(F)F)CCN1C(C=C1)=CC=C1NC(C1=NC=NN11)=NC=C1C1=CNN=C1 ZZCXQFFNUVXYKY-UHFFFAOYSA-N 0.000 claims 1
- NPDVCDFFILSPKI-UHFFFAOYSA-N 5-(1H-pyrazol-4-yl)-N-[6-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]pyridin-3-yl]-[1,2,4]triazolo[1,5-a]pyrazin-8-amine Chemical compound C1CN(CC(F)(F)F)CCN1C(N=C1)=CC=C1NC(C1=NC=NN11)=NC=C1C1=CNN=C1 NPDVCDFFILSPKI-UHFFFAOYSA-N 0.000 claims 1
- AQELFIUBLZCPAD-UHFFFAOYSA-N 5-(1h-indazol-5-yl)-n-(4-morpholin-4-ylphenyl)-[1,2,4]triazolo[1,5-a]pyrazin-8-amine Chemical compound C1COCCN1C(C=C1)=CC=C1NC(C1=NC=NN11)=NC=C1C1=CC=C(NN=C2)C2=C1 AQELFIUBLZCPAD-UHFFFAOYSA-N 0.000 claims 1
- KVFOKEDTDNGABZ-UHFFFAOYSA-N 5-(1h-indazol-6-yl)-n-(4-morpholin-4-ylphenyl)-[1,2,4]triazolo[1,5-a]pyrazin-8-amine Chemical compound C1COCCN1C(C=C1)=CC=C1NC(C1=NC=NN11)=NC=C1C1=CC=C(C=NN2)C2=C1 KVFOKEDTDNGABZ-UHFFFAOYSA-N 0.000 claims 1
- OAHJYXCKQYZNBR-UHFFFAOYSA-N 5-(1h-indazol-6-yl)-n-[4-(4-propan-2-ylpiperazin-1-yl)phenyl]-[1,2,4]triazolo[1,5-a]pyrazin-8-amine Chemical compound C1CN(C(C)C)CCN1C(C=C1)=CC=C1NC(C1=NC=NN11)=NC=C1C1=CC=C(C=NN2)C2=C1 OAHJYXCKQYZNBR-UHFFFAOYSA-N 0.000 claims 1
- XCGSKFSKSMBUSQ-UHFFFAOYSA-N 5-(2-aminopyrimidin-5-yl)-n-(4-morpholin-4-ylphenyl)-[1,2,4]triazolo[1,5-a]pyrazin-8-amine Chemical compound C1=NC(N)=NC=C1C(N1N=CN=C11)=CN=C1NC1=CC=C(N2CCOCC2)C=C1 XCGSKFSKSMBUSQ-UHFFFAOYSA-N 0.000 claims 1
- ACSIJRWNGSUPMS-UHFFFAOYSA-N 5-(5-ethyl-1H-pyrazol-4-yl)-N-(4-morpholin-4-ylphenyl)-[1,2,4]triazolo[1,5-a]pyrazin-8-amine Chemical compound N1N=CC(C=2N3N=CN=C3C(NC=3C=CC(=CC=3)N3CCOCC3)=NC=2)=C1CC ACSIJRWNGSUPMS-UHFFFAOYSA-N 0.000 claims 1
- WNDGTEUGDBKOEC-UHFFFAOYSA-N 5-(5-methyl-1H-pyrazol-4-yl)-N-(4-morpholin-4-ylphenyl)-[1,2,4]triazolo[1,5-a]pyrazin-8-amine Chemical compound N1N=CC(C=2N3N=CN=C3C(NC=3C=CC(=CC=3)N3CCOCC3)=NC=2)=C1C WNDGTEUGDBKOEC-UHFFFAOYSA-N 0.000 claims 1
- SQLDQQQSDGJHKI-CHQTWICDSA-N 5-[(e,1e)-1-(4-methylidene-1h-pyrazol-5-ylidene)but-2-en-2-yl]-n-[6-(4-propan-2-ylpiperazin-1-yl)pyridin-3-yl]-[1,2,4]triazolo[1,5-a]pyrazin-8-amine Chemical compound C=1N=C(NC=2C=NC(=CC=2)N2CCN(CC2)C(C)C)C2=NC=NN2C=1/C(=C/C)/C=C1/NN=CC1=C SQLDQQQSDGJHKI-CHQTWICDSA-N 0.000 claims 1
- IXLBIHOHNPAHSO-UHFFFAOYSA-N 5-[2-(fluoromethyl)pyridin-4-yl]-n-[4-(4-propan-2-ylpiperazin-1-yl)phenyl]-[1,2,4]triazolo[1,5-a]pyrazin-8-amine Chemical compound C1CN(C(C)C)CCN1C(C=C1)=CC=C1NC(C1=NC=NN11)=NC=C1C1=CC=NC(CF)=C1 IXLBIHOHNPAHSO-UHFFFAOYSA-N 0.000 claims 1
- KHHKVQWMBWTQMJ-UHFFFAOYSA-N 5-[8-(2-chloro-4-morpholin-4-ylanilino)-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]-2,3-dihydroisoindol-1-one Chemical compound C=1C=C(NC=2C3=NC=NN3C(C=3C=C4CNC(=O)C4=CC=3)=CN=2)C(Cl)=CC=1N1CCOCC1 KHHKVQWMBWTQMJ-UHFFFAOYSA-N 0.000 claims 1
- YVKXXZYGYSLPBB-UHFFFAOYSA-N 5-[8-(2-fluoro-4-morpholin-4-ylanilino)-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]-2,3-dihydroisoindol-1-one Chemical compound C=1C=C(NC=2C3=NC=NN3C(C=3C=C4CNC(=O)C4=CC=3)=CN=2)C(F)=CC=1N1CCOCC1 YVKXXZYGYSLPBB-UHFFFAOYSA-N 0.000 claims 1
- FLWPFGDKMLWOBV-UHFFFAOYSA-N 5-[8-(4-fluoroanilino)-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]-2,3-dihydroisoindol-1-one Chemical compound C1=CC(F)=CC=C1NC(C1=NC=NN11)=NC=C1C1=CC=C(C(=O)NC2)C2=C1 FLWPFGDKMLWOBV-UHFFFAOYSA-N 0.000 claims 1
- ZDLDULHTZCUMMG-UHFFFAOYSA-N 5-[8-(4-morpholin-4-ylanilino)-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]-2,3-dihydroisoindol-1-one Chemical compound C=1C=C2C(=O)NCC2=CC=1C(N1N=CN=C11)=CN=C1NC(C=C1)=CC=C1N1CCOCC1 ZDLDULHTZCUMMG-UHFFFAOYSA-N 0.000 claims 1
- HFFMARMJJSHTDN-UHFFFAOYSA-N 5-[8-(4-morpholin-4-ylanilino)-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]furan-3-carboxamide Chemical compound NC(=O)C1=COC(C=2N3N=CN=C3C(NC=3C=CC(=CC=3)N3CCOCC3)=NC=2)=C1 HFFMARMJJSHTDN-UHFFFAOYSA-N 0.000 claims 1
- HTAHREZOTNAEJN-UHFFFAOYSA-N 5-[8-(4-morpholin-4-ylanilino)-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]thiophene-2-carboxamide Chemical compound S1C(C(=O)N)=CC=C1C(N1N=CN=C11)=CN=C1NC1=CC=C(N2CCOCC2)C=C1 HTAHREZOTNAEJN-UHFFFAOYSA-N 0.000 claims 1
- BGKYPWASCWCHMU-UHFFFAOYSA-N 5-[8-(cyclohexylamino)-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]-2,3-dihydroisoindol-1-one Chemical compound C=1C=C2C(=O)NCC2=CC=1C(N1N=CN=C11)=CN=C1NC1CCCCC1 BGKYPWASCWCHMU-UHFFFAOYSA-N 0.000 claims 1
- UVRJZLKUVNLNDN-UHFFFAOYSA-N 5-[8-(oxan-4-ylamino)-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]-2,3-dihydroisoindol-1-one Chemical compound C=1C=C2C(=O)NCC2=CC=1C(N1N=CN=C11)=CN=C1NC1CCOCC1 UVRJZLKUVNLNDN-UHFFFAOYSA-N 0.000 claims 1
- ICKNCAUVHQVTMS-UHFFFAOYSA-N 5-[8-[(2-morpholin-4-ylpyrimidin-5-yl)amino]-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]-2,3-dihydroisoindol-1-one Chemical compound C=1C=C2C(=O)NCC2=CC=1C(N1N=CN=C11)=CN=C1NC(C=N1)=CN=C1N1CCOCC1 ICKNCAUVHQVTMS-UHFFFAOYSA-N 0.000 claims 1
- BFAUVRNFXIHEFU-UHFFFAOYSA-N 5-[8-[(6-morpholin-4-ylpyridin-3-yl)amino]-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]-2,3-dihydroisoindol-1-one Chemical compound C=1C=C2C(=O)NCC2=CC=1C(N1N=CN=C11)=CN=C1NC(C=N1)=CC=C1N1CCOCC1 BFAUVRNFXIHEFU-UHFFFAOYSA-N 0.000 claims 1
- WUIYMIHYJADQOI-UHFFFAOYSA-N 5-[8-[2-chloro-4-(4-propan-2-ylpiperazin-1-yl)anilino]-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]-2,3-dihydroisoindol-1-one Chemical compound C1CN(C(C)C)CCN1C(C=C1Cl)=CC=C1NC(C1=NC=NN11)=NC=C1C1=CC=C(C(=O)NC2)C2=C1 WUIYMIHYJADQOI-UHFFFAOYSA-N 0.000 claims 1
- ILFSKYBJCHVNJD-UHFFFAOYSA-N 5-[8-[4-(1-propan-2-ylpiperidin-4-yl)anilino]-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]-2,3-dihydroisoindol-1-one Chemical compound C1CN(C(C)C)CCC1C(C=C1)=CC=C1NC(C1=NC=NN11)=NC=C1C1=CC=C(C(=O)NC2)C2=C1 ILFSKYBJCHVNJD-UHFFFAOYSA-N 0.000 claims 1
- HBZBAYZNKWTACU-UHFFFAOYSA-N 5-[8-[4-(2-morpholin-4-ylethoxy)anilino]-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]-2,3-dihydroisoindol-1-one Chemical compound C=1C=C2C(=O)NCC2=CC=1C(N1N=CN=C11)=CN=C1NC(C=C1)=CC=C1OCCN1CCOCC1 HBZBAYZNKWTACU-UHFFFAOYSA-N 0.000 claims 1
- TYBOWYHKKVNQIB-UHFFFAOYSA-N 5-[8-[4-(2-morpholin-4-ylethoxy)anilino]-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]thiophene-2-carboxamide Chemical class S1C(C(=O)N)=CC=C1C(N1N=CN=C11)=CN=C1NC(C=C1)=CC=C1OCCN1CCOCC1 TYBOWYHKKVNQIB-UHFFFAOYSA-N 0.000 claims 1
- LSIOHAGMVUYTCY-UHFFFAOYSA-N 5-[8-[4-(2-oxo-4-propan-2-ylpiperazin-1-yl)anilino]-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]-2,3-dihydroisoindol-1-one Chemical compound O=C1CN(C(C)C)CCN1C(C=C1)=CC=C1NC(C1=NC=NN11)=NC=C1C1=CC=C(C(=O)NC2)C2=C1 LSIOHAGMVUYTCY-UHFFFAOYSA-N 0.000 claims 1
- RAJKOVRGWVJRGX-UHFFFAOYSA-N 5-[8-[4-(2-oxopiperazin-1-yl)anilino]-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]-2,3-dihydroisoindol-1-one Chemical compound C=1C=C2C(=O)NCC2=CC=1C(N1N=CN=C11)=CN=C1NC(C=C1)=CC=C1N1CCNCC1=O RAJKOVRGWVJRGX-UHFFFAOYSA-N 0.000 claims 1
- HEAMBSUSRXMHHW-UHFFFAOYSA-N 5-[8-[4-(4-methylpiperazin-1-yl)anilino]-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]thiophene-2-carboxamide Chemical class C1CN(C)CCN1C(C=C1)=CC=C1NC(C1=NC=NN11)=NC=C1C1=CC=C(C(N)=O)S1 HEAMBSUSRXMHHW-UHFFFAOYSA-N 0.000 claims 1
- VTESFAODZQAOKN-UHFFFAOYSA-N 5-[8-[4-(4-propan-2-ylpiperazin-1-yl)anilino]-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]-2,3-dihydroisoindol-1-one Chemical compound C1CN(C(C)C)CCN1C(C=C1)=CC=C1NC(C1=NC=NN11)=NC=C1C1=CC=C(C(=O)NC2)C2=C1 VTESFAODZQAOKN-UHFFFAOYSA-N 0.000 claims 1
- QDFALLADGCIINW-UHFFFAOYSA-N 5-[8-[4-(4-propan-2-ylpiperazin-1-yl)anilino]-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]furan-3-carboxamide Chemical class C1CN(C(C)C)CCN1C(C=C1)=CC=C1NC(C1=NC=NN11)=NC=C1C1=CC(C(N)=O)=CO1 QDFALLADGCIINW-UHFFFAOYSA-N 0.000 claims 1
- SOSKZUMAFVMCJD-UHFFFAOYSA-N 5-[8-[4-(4-tert-butylpiperazin-1-yl)anilino]-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]-2,3-dihydroisoindol-1-one Chemical compound C1CN(C(C)(C)C)CCN1C(C=C1)=CC=C1NC(C1=NC=NN11)=NC=C1C1=CC=C(C(=O)NC2)C2=C1 SOSKZUMAFVMCJD-UHFFFAOYSA-N 0.000 claims 1
- QWICPTNWZITFIH-UHFFFAOYSA-N 5-[8-[[2-(4-propan-2-ylpiperazin-1-yl)pyrimidin-5-yl]amino]-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]-2,3-dihydroisoindol-1-one Chemical compound C1CN(C(C)C)CCN1C(N=C1)=NC=C1NC(C1=NC=NN11)=NC=C1C1=CC=C(C(=O)NC2)C2=C1 QWICPTNWZITFIH-UHFFFAOYSA-N 0.000 claims 1
- KUPXYNXWFGYIDC-UHFFFAOYSA-N 5-[8-[[6-(4-propan-2-ylpiperazin-1-yl)pyridin-3-yl]amino]-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]-2,3-dihydroisoindol-1-one Chemical compound C1CN(C(C)C)CCN1C(N=C1)=CC=C1NC(C1=NC=NN11)=NC=C1C1=CC=C(C(=O)NC2)C2=C1 KUPXYNXWFGYIDC-UHFFFAOYSA-N 0.000 claims 1
- HEWBNUXVXLZAIL-UHFFFAOYSA-N 5-methyl-4-[8-[4-(4-propan-2-ylpiperazin-1-yl)anilino]-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]thiophene-2-carboxamide Chemical compound C1CN(C(C)C)CCN1C(C=C1)=CC=C1NC(C1=NC=NN11)=NC=C1C1=C(C)SC(C(N)=O)=C1 HEWBNUXVXLZAIL-UHFFFAOYSA-N 0.000 claims 1
- NCVBQABZBTUPSS-UHFFFAOYSA-N 5-methyl-4-[8-[[6-(4-propan-2-ylpiperazin-1-yl)pyridin-3-yl]amino]-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]thiophene-2-carboxamide Chemical compound C1CN(C(C)C)CCN1C(N=C1)=CC=C1NC(C1=NC=NN11)=NC=C1C1=C(C)SC(C(N)=O)=C1 NCVBQABZBTUPSS-UHFFFAOYSA-N 0.000 claims 1
- OLRQTQQXZWALSE-UHFFFAOYSA-N 6-[8-(4-morpholin-4-ylanilino)-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]-1,1-dioxo-1,2-benzothiazol-3-one Chemical compound C=1C=C2C(=O)NS(=O)(=O)C2=CC=1C(N1N=CN=C11)=CN=C1NC(C=C1)=CC=C1N1CCOCC1 OLRQTQQXZWALSE-UHFFFAOYSA-N 0.000 claims 1
- PALGDWJTQMYOBB-UHFFFAOYSA-N 6-[8-(4-morpholin-4-ylanilino)-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]-3,4-dihydro-1h-quinolin-2-one Chemical compound C=1C=C2NC(=O)CCC2=CC=1C(N1N=CN=C11)=CN=C1NC(C=C1)=CC=C1N1CCOCC1 PALGDWJTQMYOBB-UHFFFAOYSA-N 0.000 claims 1
- JYSUCBWHMKZUBP-UHFFFAOYSA-N 6-[8-(4-morpholin-4-ylanilino)-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]-3,4-dihydro-2h-isoquinolin-1-one Chemical compound C=1C=C2C(=O)NCCC2=CC=1C(N1N=CN=C11)=CN=C1NC(C=C1)=CC=C1N1CCOCC1 JYSUCBWHMKZUBP-UHFFFAOYSA-N 0.000 claims 1
- GNRIPRYGEHPLEE-UHFFFAOYSA-N 6-[8-[4-(4-propan-2-ylpiperazin-1-yl)anilino]-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]-2,3-dihydroisoindol-1-one Chemical compound C1CN(C(C)C)CCN1C(C=C1)=CC=C1NC(C1=NC=NN11)=NC=C1C1=CC=C(CNC2=O)C2=C1 GNRIPRYGEHPLEE-UHFFFAOYSA-N 0.000 claims 1
- OGPDZYDHCXSOGK-UHFFFAOYSA-N 7-fluoro-5-[8-[4-(4-propan-2-ylpiperazin-1-yl)anilino]-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]-2,3-dihydroisoindol-1-one Chemical compound C1CN(C(C)C)CCN1C(C=C1)=CC=C1NC(C1=NC=NN11)=NC=C1C(C=C1F)=CC2=C1C(=O)NC2 OGPDZYDHCXSOGK-UHFFFAOYSA-N 0.000 claims 1
- 206010061218 Inflammation Diseases 0.000 claims 1
- MTSRYHYGIQXQMX-UHFFFAOYSA-N N,N-diethyl-3-[[5-(1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyrazin-8-yl]amino]benzamide Chemical compound CCN(CC)C(=O)C1=CC=CC(NC=2C3=NC=NN3C(C3=CNN=C3)=CN=2)=C1 MTSRYHYGIQXQMX-UHFFFAOYSA-N 0.000 claims 1
- YFJMVYXVCJHALM-UHFFFAOYSA-N N-(1-methoxybutan-2-yl)-4-[[5-(1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyrazin-8-yl]amino]benzamide Chemical compound C1=CC(C(=O)NC(COC)CC)=CC=C1NC(C1=NC=NN11)=NC=C1C1=CNN=C1 YFJMVYXVCJHALM-UHFFFAOYSA-N 0.000 claims 1
- NEWGXMFUOOHJFY-UHFFFAOYSA-N N-(2-chloro-4-morpholin-4-ylphenyl)-5-(1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyrazin-8-amine Chemical compound ClC1=CC(N2CCOCC2)=CC=C1NC(C1=NC=NN11)=NC=C1C=1C=NNC=1 NEWGXMFUOOHJFY-UHFFFAOYSA-N 0.000 claims 1
- XPWKDQHOFGSYMT-UHFFFAOYSA-N N-(2-fluoro-4-morpholin-4-ylphenyl)-5-(1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyrazin-8-amine Chemical compound FC1=CC(N2CCOCC2)=CC=C1NC(C1=NC=NN11)=NC=C1C=1C=NNC=1 XPWKDQHOFGSYMT-UHFFFAOYSA-N 0.000 claims 1
- RRHNHWZSMNRGDX-UHFFFAOYSA-N N-(2-hydroxyethyl)-4-[[5-(1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyrazin-8-yl]amino]benzamide Chemical compound C1=CC(C(=O)NCCO)=CC=C1NC(C1=NC=NN11)=NC=C1C1=CNN=C1 RRHNHWZSMNRGDX-UHFFFAOYSA-N 0.000 claims 1
- PAAIFMTUVCLKQC-UHFFFAOYSA-N N-(2-methoxyethyl)-N-methyl-4-[[5-(1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyrazin-8-yl]amino]benzamide Chemical compound C1=CC(C(=O)N(C)CCOC)=CC=C1NC(C1=NC=NN11)=NC=C1C1=CNN=C1 PAAIFMTUVCLKQC-UHFFFAOYSA-N 0.000 claims 1
- AKVMWXGPLVFCEI-UHFFFAOYSA-N N-(2-methylpropyl)-4-[[5-(1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyrazin-8-yl]amino]benzamide Chemical compound C1=CC(C(=O)NCC(C)C)=CC=C1NC(C1=NC=NN11)=NC=C1C1=CNN=C1 AKVMWXGPLVFCEI-UHFFFAOYSA-N 0.000 claims 1
- LXHGRBBZPPHGGU-UHFFFAOYSA-N N-(2-methylsulfanylethyl)-4-[[5-(1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyrazin-8-yl]amino]benzamide Chemical compound C1=CC(C(=O)NCCSC)=CC=C1NC(C1=NC=NN11)=NC=C1C1=CNN=C1 LXHGRBBZPPHGGU-UHFFFAOYSA-N 0.000 claims 1
- FSJCOVNZMNCDIL-UHFFFAOYSA-N N-(3-chloro-4-morpholin-4-ylphenyl)-5-(1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyrazin-8-amine Chemical compound C=1C=C(N2CCOCC2)C(Cl)=CC=1NC(C1=NC=NN11)=NC=C1C=1C=NNC=1 FSJCOVNZMNCDIL-UHFFFAOYSA-N 0.000 claims 1
- YWZYXGXFZBNCHH-UHFFFAOYSA-N N-(3-fluoro-4-morpholin-4-ylphenyl)-5-(1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyrazin-8-amine Chemical compound C=1C=C(N2CCOCC2)C(F)=CC=1NC(C1=NC=NN11)=NC=C1C=1C=NNC=1 YWZYXGXFZBNCHH-UHFFFAOYSA-N 0.000 claims 1
- WLARYAYYWFBBOV-UHFFFAOYSA-N N-(4-piperazin-1-ylphenyl)-5-(1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyrazin-8-amine Chemical compound C1CNCCN1C(C=C1)=CC=C1NC(C1=NC=NN11)=NC=C1C1=CNN=C1 WLARYAYYWFBBOV-UHFFFAOYSA-N 0.000 claims 1
- UNLXXDRQUAZKAE-UHFFFAOYSA-N N-(6-morpholin-4-ylpyridin-3-yl)-5-(1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyrazin-8-amine Chemical compound C1COCCN1C(N=C1)=CC=C1NC(C1=NC=NN11)=NC=C1C1=CNN=C1 UNLXXDRQUAZKAE-UHFFFAOYSA-N 0.000 claims 1
- RYOMLAGHZHSREA-UHFFFAOYSA-N N-(cyclohexylmethyl)-3-[[5-(1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyrazin-8-yl]amino]benzamide Chemical compound C=1C=CC(NC=2C3=NC=NN3C(C3=CNN=C3)=CN=2)=CC=1C(=O)NCC1CCCCC1 RYOMLAGHZHSREA-UHFFFAOYSA-N 0.000 claims 1
- MVEUFYRLTOZSJT-UHFFFAOYSA-N N-(cyclopropylmethyl)-4-[[5-(1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyrazin-8-yl]amino]benzamide Chemical compound C=1C=C(NC=2C3=NC=NN3C(C3=CNN=C3)=CN=2)C=CC=1C(=O)NCC1CC1 MVEUFYRLTOZSJT-UHFFFAOYSA-N 0.000 claims 1
- HZLPDXPHNYIARB-UHFFFAOYSA-N N-(oxolan-2-ylmethyl)-4-[[5-(1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyrazin-8-yl]amino]benzamide Chemical compound C=1C=C(NC=2C3=NC=NN3C(C3=CNN=C3)=CN=2)C=CC=1C(=O)NCC1CCCO1 HZLPDXPHNYIARB-UHFFFAOYSA-N 0.000 claims 1
- DGACUWHSLZOGAZ-UHFFFAOYSA-N N-[(1-ethylpyrrolidin-2-yl)methyl]-4-[[5-(1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyrazin-8-yl]amino]benzamide Chemical compound CCN1CCCC1CNC(=O)C(C=C1)=CC=C1NC(C1=NC=NN11)=NC=C1C1=CNN=C1 DGACUWHSLZOGAZ-UHFFFAOYSA-N 0.000 claims 1
- SLTAWZFGJNRSMG-UHFFFAOYSA-N N-[(2,2-dimethyl-1,3-dioxolan-4-yl)methyl]-4-[[5-(1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyrazin-8-yl]amino]benzamide Chemical compound O1C(C)(C)OCC1CNC(=O)C(C=C1)=CC=C1NC(C1=NC=NN11)=NC=C1C1=CNN=C1 SLTAWZFGJNRSMG-UHFFFAOYSA-N 0.000 claims 1
- LAXGDSVMTVKGEB-JOCHJYFZSA-N N-[(3R)-1-benzylpyrrolidin-3-yl]-4-[[5-(1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyrazin-8-yl]amino]benzamide Chemical compound C([C@H](C1)NC(=O)C=2C=CC(NC=3C4=NC=NN4C(C4=CNN=C4)=CN=3)=CC=2)CN1CC1=CC=CC=C1 LAXGDSVMTVKGEB-JOCHJYFZSA-N 0.000 claims 1
- IHQUHWZSQCNJBO-UHFFFAOYSA-N N-[(4-hydroxyphenyl)methyl]-3-[[5-(1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyrazin-8-yl]amino]benzamide Chemical compound C1=CC(O)=CC=C1CNC(=O)C1=CC=CC(NC=2C3=NC=NN3C(C3=CNN=C3)=CN=2)=C1 IHQUHWZSQCNJBO-UHFFFAOYSA-N 0.000 claims 1
- GSPOMBOIVYFWKH-UHFFFAOYSA-N N-[2-[di(propan-2-yl)amino]ethyl]-4-[[5-(1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyrazin-8-yl]amino]benzamide Chemical compound C1=CC(C(=O)NCCN(C(C)C)C(C)C)=CC=C1NC(C1=NC=NN11)=NC=C1C1=CNN=C1 GSPOMBOIVYFWKH-UHFFFAOYSA-N 0.000 claims 1
- LTADIOIOIONVLW-UHFFFAOYSA-N N-[4-(4-cyclopropylpiperazin-1-yl)phenyl]-5-(1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyrazin-8-amine Chemical compound C1CC1N1CCN(C=2C=CC(NC=3C4=NC=NN4C(C4=CNN=C4)=CN=3)=CC=2)CC1 LTADIOIOIONVLW-UHFFFAOYSA-N 0.000 claims 1
- BNUAGQIURUKXFB-UHFFFAOYSA-N N-[4-(4-methylpiperazin-1-yl)phenyl]-4-[[5-(1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyrazin-8-yl]amino]benzamide Chemical compound C1CN(C)CCN1C(C=C1)=CC=C1NC(=O)C(C=C1)=CC=C1NC(C1=NC=NN11)=NC=C1C1=CNN=C1 BNUAGQIURUKXFB-UHFFFAOYSA-N 0.000 claims 1
- KEJPHZROOKODRB-UHFFFAOYSA-N N-[4-(4-methylpiperazin-1-yl)phenyl]-5-(5-methyl-1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyrazin-8-amine Chemical compound C1CN(C)CCN1C(C=C1)=CC=C1NC(C1=NC=NN11)=NC=C1C1=C(C)NN=C1 KEJPHZROOKODRB-UHFFFAOYSA-N 0.000 claims 1
- SJFCALIVDFEXCP-UHFFFAOYSA-N N-[4-[4-(cyclopropylmethyl)piperazin-1-yl]phenyl]-5-(1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyrazin-8-amine Chemical compound C1CN(C=2C=CC(NC=3C4=NC=NN4C(C4=CNN=C4)=CN=3)=CC=2)CCN1CC1CC1 SJFCALIVDFEXCP-UHFFFAOYSA-N 0.000 claims 1
- SRKUNLZTJIAOGZ-UHFFFAOYSA-N N-[5-[[5-(1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyrazin-8-yl]amino]pyridin-2-yl]benzamide Chemical compound C=1C=CC=CC=1C(=O)NC(N=C1)=CC=C1NC(C1=NC=NN11)=NC=C1C=1C=NNC=1 SRKUNLZTJIAOGZ-UHFFFAOYSA-N 0.000 claims 1
- JINMLVRMKSGVRV-UHFFFAOYSA-N N-[6-(4-propan-2-ylpiperazin-1-yl)pyridin-3-yl]-5-(1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyrazin-8-amine Chemical compound C1CN(C(C)C)CCN1C(N=C1)=CC=C1NC(C1=NC=NN11)=NC=C1C1=CNN=C1 JINMLVRMKSGVRV-UHFFFAOYSA-N 0.000 claims 1
- FCYIPZNUCTWQFY-UHFFFAOYSA-N N-[6-[4-(cyclopropylmethyl)piperazin-1-yl]pyridin-3-yl]-5-(1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyrazin-8-amine Chemical compound C1CN(C=2N=CC(NC=3C4=NC=NN4C(C4=CNN=C4)=CN=3)=CC=2)CCN1CC1CC1 FCYIPZNUCTWQFY-UHFFFAOYSA-N 0.000 claims 1
- DGACUWHSLZOGAZ-SFHVURJKSA-N N-[[(2S)-1-ethylpyrrolidin-2-yl]methyl]-4-[[5-(1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyrazin-8-yl]amino]benzamide Chemical compound CCN1CCC[C@H]1CNC(=O)C(C=C1)=CC=C1NC(C1=NC=NN11)=NC=C1C1=CNN=C1 DGACUWHSLZOGAZ-SFHVURJKSA-N 0.000 claims 1
- MIRIRWWYQHEKPE-UHFFFAOYSA-N N-benzyl-2-methoxy-4-[[5-(1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyrazin-8-yl]amino]benzamide Chemical compound C=1C=C(C(=O)NCC=2C=CC=CC=2)C(OC)=CC=1NC(C1=NC=NN11)=NC=C1C=1C=NNC=1 MIRIRWWYQHEKPE-UHFFFAOYSA-N 0.000 claims 1
- GBIAFQRZAYQVBC-UHFFFAOYSA-N N-benzyl-3-[[5-(1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyrazin-8-yl]amino]benzamide Chemical compound C=1C=CC(NC=2C3=NC=NN3C(C3=CNN=C3)=CN=2)=CC=1C(=O)NCC1=CC=CC=C1 GBIAFQRZAYQVBC-UHFFFAOYSA-N 0.000 claims 1
- IKEUUXDJMMATCV-UHFFFAOYSA-N N-benzyl-N-methyl-3-[[5-(1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyrazin-8-yl]amino]benzamide Chemical compound C=1C=CC(NC=2C3=NC=NN3C(C3=CNN=C3)=CN=2)=CC=1C(=O)N(C)CC1=CC=CC=C1 IKEUUXDJMMATCV-UHFFFAOYSA-N 0.000 claims 1
- RPBFPZSBRGQZAF-UHFFFAOYSA-N N-ethyl-3-[[5-(1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyrazin-8-yl]amino]benzamide Chemical compound CCNC(=O)C1=CC=CC(NC=2C3=NC=NN3C(C3=CNN=C3)=CN=2)=C1 RPBFPZSBRGQZAF-UHFFFAOYSA-N 0.000 claims 1
- MRMRRGWJZIPTEQ-UHFFFAOYSA-N N-ethyl-N-(2-methoxyethyl)-4-[[5-(1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyrazin-8-yl]amino]benzamide Chemical compound C1=CC(C(=O)N(CCOC)CC)=CC=C1NC(C1=NC=NN11)=NC=C1C1=CNN=C1 MRMRRGWJZIPTEQ-UHFFFAOYSA-N 0.000 claims 1
- FGJJUTFVNJSGHQ-UHFFFAOYSA-N N-methyl-1-[4-[[5-(1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyrazin-8-yl]amino]benzoyl]piperidine-4-carboxamide Chemical compound C1CC(C(=O)NC)CCN1C(=O)C(C=C1)=CC=C1NC(C1=NC=NN11)=NC=C1C1=CNN=C1 FGJJUTFVNJSGHQ-UHFFFAOYSA-N 0.000 claims 1
- NYBGGMPLCJTBCY-UHFFFAOYSA-N N-methyl-N-[1-[4-[[5-(1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyrazin-8-yl]amino]benzoyl]pyrrolidin-3-yl]acetamide Chemical compound C1C(N(C)C(C)=O)CCN1C(=O)C(C=C1)=CC=C1NC(C1=NC=NN11)=NC=C1C1=CNN=C1 NYBGGMPLCJTBCY-UHFFFAOYSA-N 0.000 claims 1
- AVAQBDJGLMVHMR-UHFFFAOYSA-N N-propan-2-yl-2-[4-[4-[[5-(1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyrazin-8-yl]amino]benzoyl]piperazin-1-yl]acetamide Chemical compound C1CN(CC(=O)NC(C)C)CCN1C(=O)C(C=C1)=CC=C1NC(C1=NC=NN11)=NC=C1C1=CNN=C1 AVAQBDJGLMVHMR-UHFFFAOYSA-N 0.000 claims 1
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 claims 1
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Natural products C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 claims 1
- JFDPEWDADGRRQZ-UHFFFAOYSA-N [2-morpholin-4-yl-5-[[5-(1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyrazin-8-yl]amino]phenyl]methanol Chemical compound C=1C=C(N2CCOCC2)C(CO)=CC=1NC(C1=NC=NN11)=NC=C1C=1C=NNC=1 JFDPEWDADGRRQZ-UHFFFAOYSA-N 0.000 claims 1
- SSPDVDXYRRZJBK-UHFFFAOYSA-N [3-[[5-(1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyrazin-8-yl]amino]phenyl]-pyrrolidin-1-ylmethanone Chemical compound C=1C=CC(NC=2C3=NC=NN3C(C3=CNN=C3)=CN=2)=CC=1C(=O)N1CCCC1 SSPDVDXYRRZJBK-UHFFFAOYSA-N 0.000 claims 1
- IFMOEGNAPRSVHB-UHFFFAOYSA-N [4-(2-ethoxyethyl)piperazin-1-yl]-[4-[[5-(1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyrazin-8-yl]amino]phenyl]methanone Chemical compound C1CN(CCOCC)CCN1C(=O)C(C=C1)=CC=C1NC(C1=NC=NN11)=NC=C1C1=CNN=C1 IFMOEGNAPRSVHB-UHFFFAOYSA-N 0.000 claims 1
- RZKJJLFMOSCVCC-UHFFFAOYSA-N [4-(2-methoxyethyl)piperazin-1-yl]-[4-[[5-(1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyrazin-8-yl]amino]phenyl]methanone Chemical compound C1CN(CCOC)CCN1C(=O)C(C=C1)=CC=C1NC(C1=NC=NN11)=NC=C1C1=CNN=C1 RZKJJLFMOSCVCC-UHFFFAOYSA-N 0.000 claims 1
- XXXRYBDZRYYDSC-UHFFFAOYSA-N [4-[(4-fluorophenyl)methyl]piperazin-1-yl]-[4-[[5-(1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyrazin-8-yl]amino]phenyl]methanone Chemical compound C1=CC(F)=CC=C1CN1CCN(C(=O)C=2C=CC(NC=3C4=NC=NN4C(C4=CNN=C4)=CN=3)=CC=2)CC1 XXXRYBDZRYYDSC-UHFFFAOYSA-N 0.000 claims 1
- NFPDZRYLXOILPI-UHFFFAOYSA-N [4-[8-(4-morpholin-4-ylanilino)-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]-1H-pyrazol-5-yl]methanol Chemical compound N1N=CC(C=2N3N=CN=C3C(NC=3C=CC(=CC=3)N3CCOCC3)=NC=2)=C1CO NFPDZRYLXOILPI-UHFFFAOYSA-N 0.000 claims 1
- CPICEHFVWBSXJW-UHFFFAOYSA-N [4-[8-(4-morpholin-4-ylanilino)-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]pyridin-2-yl]methanol Chemical compound C1=NC(CO)=CC(C=2N3N=CN=C3C(NC=3C=CC(=CC=3)N3CCOCC3)=NC=2)=C1 CPICEHFVWBSXJW-UHFFFAOYSA-N 0.000 claims 1
- XMGJRIGZLBBPSS-UHFFFAOYSA-N [4-[8-[4-(4-propan-2-ylpiperazin-1-yl)anilino]-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]pyridin-2-yl]methanol Chemical compound C1CN(C(C)C)CCN1C(C=C1)=CC=C1NC(C1=NC=NN11)=NC=C1C1=CC=NC(CO)=C1 XMGJRIGZLBBPSS-UHFFFAOYSA-N 0.000 claims 1
- WIWYXIDDANSIFL-UHFFFAOYSA-N [4-[8-[[6-(4-propan-2-ylpiperazin-1-yl)pyridin-3-yl]amino]-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]pyridin-2-yl]methanol Chemical compound C1CN(C(C)C)CCN1C(N=C1)=CC=C1NC(C1=NC=NN11)=NC=C1C1=CC=NC(CO)=C1 WIWYXIDDANSIFL-UHFFFAOYSA-N 0.000 claims 1
- 125000002947 alkylene group Chemical group 0.000 claims 1
- 150000001408 amides Chemical class 0.000 claims 1
- 230000015556 catabolic process Effects 0.000 claims 1
- WSPYBPVYCFYIRM-UHFFFAOYSA-N chembl1956687 Chemical compound C1COCCN1C(C=C1)=CC=C1NC(C1=NC=NN11)=NC=C1C1=CNN=C1 WSPYBPVYCFYIRM-UHFFFAOYSA-N 0.000 claims 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims 1
- 238000006731 degradation reaction Methods 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- KLQOYDSXKWIVMJ-UHFFFAOYSA-N ethyl 2-[benzyl-[4-[[5-(1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyrazin-8-yl]amino]benzoyl]amino]acetate Chemical compound C=1C=C(NC=2C3=NC=NN3C(C3=CNN=C3)=CN=2)C=CC=1C(=O)N(CC(=O)OCC)CC1=CC=CC=C1 KLQOYDSXKWIVMJ-UHFFFAOYSA-N 0.000 claims 1
- 125000002541 furyl group Chemical group 0.000 claims 1
- 125000004474 heteroalkylene group Chemical group 0.000 claims 1
- 150000002460 imidazoles Chemical class 0.000 claims 1
- 125000001041 indolyl group Chemical group 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims 1
- 125000000904 isoindolyl group Chemical group C=1(NC=C2C=CC=CC12)* 0.000 claims 1
- 125000004458 methylaminocarbonyl group Chemical group [H]N(C(*)=O)C([H])([H])[H] 0.000 claims 1
- VSHZLKVKHKMKFB-UHFFFAOYSA-N n-(4-morpholin-4-ylphenyl)-5-(1h-pyrazol-5-yl)-[1,2,4]triazolo[1,5-a]pyrazin-8-amine Chemical compound C1COCCN1C(C=C1)=CC=C1NC(C1=NC=NN11)=NC=C1C1=CC=NN1 VSHZLKVKHKMKFB-UHFFFAOYSA-N 0.000 claims 1
- PBERAIPVANFQPF-UHFFFAOYSA-N n-(4-morpholin-4-ylphenyl)-5-thiophen-3-yl-[1,2,4]triazolo[1,5-a]pyrazin-8-amine Chemical compound C1COCCN1C(C=C1)=CC=C1NC(C1=NC=NN11)=NC=C1C1=CSC=C1 PBERAIPVANFQPF-UHFFFAOYSA-N 0.000 claims 1
- ZJKDVULACFEGOT-UHFFFAOYSA-N n-[4-(4-propan-2-ylpiperazin-1-yl)phenyl]-5-thiophen-3-yl-[1,2,4]triazolo[1,5-a]pyrazin-8-amine Chemical compound C1CN(C(C)C)CCN1C(C=C1)=CC=C1NC(C1=NC=NN11)=NC=C1C1=CSC=C1 ZJKDVULACFEGOT-UHFFFAOYSA-N 0.000 claims 1
- BDKKNNARTAMORY-UHFFFAOYSA-N n-methyl-4-[8-(4-morpholin-4-ylanilino)-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]-1,3-thiazole-2-carboxamide Chemical compound S1C(C(=O)NC)=NC(C=2N3N=CN=C3C(NC=3C=CC(=CC=3)N3CCOCC3)=NC=2)=C1 BDKKNNARTAMORY-UHFFFAOYSA-N 0.000 claims 1
- UPWIOQFFWNNUKK-UHFFFAOYSA-N n-methyl-4-[8-[4-(4-propan-2-ylpiperazin-1-yl)anilino]-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]-1,3-thiazole-2-carboxamide Chemical compound S1C(C(=O)NC)=NC(C=2N3N=CN=C3C(NC=3C=CC(=CC=3)N3CCN(CC3)C(C)C)=NC=2)=C1 UPWIOQFFWNNUKK-UHFFFAOYSA-N 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 125000002971 oxazolyl group Chemical group 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 150000003053 piperidines Chemical class 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- 150000003216 pyrazines Chemical class 0.000 claims 1
- 150000003217 pyrazoles Chemical class 0.000 claims 1
- 125000003226 pyrazolyl group Chemical group 0.000 claims 1
- 150000003233 pyrroles Chemical class 0.000 claims 1
- 125000000168 pyrrolyl group Chemical group 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
- NQRYJNQNLNOLGT-UHFFFAOYSA-N tetrahydropyridine hydrochloride Natural products C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims 1
- 125000000335 thiazolyl group Chemical group 0.000 claims 1
- 125000001544 thienyl group Chemical group 0.000 claims 1
- 0 C*1*S*(*)CC1 Chemical compound C*1*S*(*)CC1 0.000 description 1
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US80355206P | 2006-05-31 | 2006-05-31 | |
| US93184407P | 2007-05-25 | 2007-05-25 | |
| US93176407P | 2007-05-25 | 2007-05-25 | |
| US93176307P | 2007-05-25 | 2007-05-25 | |
| US93210007P | 2007-05-29 | 2007-05-29 | |
| PCT/EP2007/055246 WO2007138072A2 (en) | 2006-05-31 | 2007-05-30 | Triazolopyrazine compounds useful for the treatment of degenerative & inflammatory diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009538877A JP2009538877A (ja) | 2009-11-12 |
| JP2009538877A5 true JP2009538877A5 (enExample) | 2010-08-26 |
Family
ID=38618932
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009512585A Abandoned JP2009538877A (ja) | 2006-05-31 | 2007-05-30 | 変性疾患及び炎症性疾患の治療に有用なトリアゾロピラジン化合物 |
Country Status (20)
| Country | Link |
|---|---|
| US (3) | US7501411B2 (enExample) |
| JP (1) | JP2009538877A (enExample) |
| KR (1) | KR20090026288A (enExample) |
| AT (1) | ATE465164T1 (enExample) |
| AU (1) | AU2007267121A1 (enExample) |
| BR (1) | BRPI0712531A2 (enExample) |
| CA (1) | CA2653506A1 (enExample) |
| CR (1) | CR10458A (enExample) |
| DE (1) | DE602007006010D1 (enExample) |
| DK (1) | DK2029602T3 (enExample) |
| EA (1) | EA200870592A1 (enExample) |
| EC (1) | ECSP088923A (enExample) |
| HR (1) | HRP20100378T1 (enExample) |
| IL (1) | IL195033A0 (enExample) |
| MX (1) | MX2008015057A (enExample) |
| NI (1) | NI200800299A (enExample) |
| NO (1) | NO20084703L (enExample) |
| NZ (1) | NZ573015A (enExample) |
| PT (1) | PT2029602E (enExample) |
| WO (1) | WO2007138072A2 (enExample) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2652440T3 (es) * | 2004-04-02 | 2018-02-02 | OSI Pharmaceuticals, LLC | Inhibidores de proteína cinasa heterobicíclicos sustituidos con anillo 6,6-bicíclico |
| US7893058B2 (en) * | 2006-05-15 | 2011-02-22 | Janssen Pharmaceutica Nv | Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases |
| WO2007138072A2 (en) * | 2006-05-31 | 2007-12-06 | Galapagos N.V. | Triazolopyrazine compounds useful for the treatment of degenerative & inflammatory diseases |
| ATE495743T1 (de) | 2006-12-01 | 2011-02-15 | Galapagos Nv | Triazolopyridinverbindungen zur behandlung von degenerations- und entzündungskrankheiten |
| US8148369B2 (en) | 2007-05-10 | 2012-04-03 | Janssen Pharmaceutica Nv | Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseases |
| US8133895B2 (en) * | 2007-05-10 | 2012-03-13 | Janssen Pharmaceutica N.V. | Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseases |
| DE102007060172A1 (de) | 2007-12-13 | 2009-06-25 | Bayer Healthcare Ag | Triazolotriazine und Triazolopyrazine und ihre Verwendung |
| DE102008035209A1 (de) | 2008-07-29 | 2010-02-04 | Bayer Schering Pharma Aktiengesellschaft | Triazolotriazine und Triazolopyrazine und ihre Verwendung |
| CL2009001064A1 (es) * | 2008-05-07 | 2009-10-09 | Galapagos Nv | Compuestos derivados de imidazol-pirazina o triazol-pirazina fusionados, inhibidores de mapkapk5; composicion farmaceutica que comprende dichos compuestos; y uso para preparar un medicamento destinado al tratamiento de inflamacion, especialmente en la artritis reumatoide. |
| DE102008023801A1 (de) | 2008-05-15 | 2009-11-19 | Bayer Schering Pharma Aktiengesellschaft | Substituierte Imidazo- und Triazolopyrimidine, Imidazo- und Pyrazolopyrazine und Imidazotriazine |
| TWI453207B (zh) | 2008-09-08 | 2014-09-21 | Signal Pharm Llc | 胺基三唑并吡啶，其組合物及使用其之治療方法 |
| WO2010123792A1 (en) | 2009-04-20 | 2010-10-28 | Osi Pharmaceuticals, Inc. | Preparation of c-pyrazine-methylamines |
| EP2427192A1 (en) * | 2009-05-07 | 2012-03-14 | OSI Pharmaceuticals, LLC | Use of osi-906 for treating adrenocortical carcinoma |
| TW201120043A (en) * | 2009-11-05 | 2011-06-16 | Galapagos Nv | Fused pyrazine compounds as their salts, useful for the treatment of degenerative and inflammatory diseases |
| EP2343297A1 (en) | 2009-11-30 | 2011-07-13 | Bayer Schering Pharma AG | Triazolopyridines |
| TW201200518A (en) * | 2010-03-10 | 2012-01-01 | Kalypsys Inc | Heterocyclic inhibitors of histamine receptors for the treatment of disease |
| US9512126B2 (en) | 2012-03-14 | 2016-12-06 | Bayer Intellectual Property Gmbh | Substituted imidazopyridazines |
| AP2015008898A0 (en) | 2013-06-11 | 2015-12-31 | Bayer Pharma AG | Prodrug derivatives of substituted triazolopyridines |
| EP3010922B1 (en) * | 2013-06-19 | 2017-03-15 | Galapagos NV | Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders |
| ES2683693T3 (es) | 2014-01-03 | 2018-09-27 | Bayer Animal Health Gmbh | Nuevas pirazolil-heteroarilamidas como agentes plaguicidas |
| EP3137454A1 (en) | 2014-04-28 | 2017-03-08 | Pfizer Inc. | Heteroaromatic compounds and their use as dopamine d1 ligands |
| KR20180030545A (ko) | 2015-06-22 | 2018-03-23 | 다이닛본 스미토모 세이야꾸 가부시끼가이샤 | 바이사이클릭 헤테로사이클릭 아미드 유도체 |
| RS62639B1 (sr) | 2015-07-06 | 2021-12-31 | Alkermes Inc | Hetero-halo inhibitori histonskih deacetilaza |
| US10421756B2 (en) | 2015-07-06 | 2019-09-24 | Rodin Therapeutics, Inc. | Heterobicyclic N-aminophenyl-amides as inhibitors of histone deacetylase |
| US10898469B2 (en) | 2016-02-26 | 2021-01-26 | Sumitomo Dainippon Pharma Co., Ltd. | Imidazolylamide derivative |
| PE20190624A1 (es) | 2016-07-12 | 2019-04-26 | Revolution Medicines Inc | 3-metil pirazinas 2,5-disustituidas y 3-metil pirazinas 2,5,6-trisustituidas como inhibidores alostericos de shp2 |
| MD3570834T2 (ro) | 2017-01-11 | 2022-04-30 | Alkermes Inc | Inhibitori biciclici ai histon deacetilazei |
| EP3571189B1 (en) | 2017-01-23 | 2023-03-29 | Revolution Medicines, Inc. | Pyridine compounds as allosteric shp2 inhibitors |
| CN117327075A (zh) | 2017-01-23 | 2024-01-02 | 锐新医药公司 | 作为变构shp2抑制剂的二环化合物 |
| CN109206357A (zh) * | 2017-07-04 | 2019-01-15 | 浙江九洲药业股份有限公司 | 一种格列齐特中间体的通式化合物及其制备方法和应用 |
| JP7152471B2 (ja) | 2017-08-07 | 2022-10-12 | ロダン・セラピューティクス，インコーポレーテッド | ヒストン脱アセチル化酵素の二環阻害剤 |
| AU2018347516A1 (en) | 2017-10-12 | 2020-05-07 | Revolution Medicines, Inc. | Pyridine, pyrazine, and triazine compounds as allosteric SHP2 inhibitors |
| EP3724189B1 (en) | 2017-12-15 | 2023-10-04 | Revolution Medicines, Inc. | Polycyclic compounds as allosteric shp2 inhibitors |
| CR20230030A (es) | 2018-02-27 | 2023-03-10 | Incyte Corp | Imidazopirimidinas y triazolopirimidinas como inhibidores de a2a / a2b (divisional 2020-0441) |
| CN108379583B (zh) * | 2018-03-27 | 2021-08-17 | 北京大学 | 一种肿瘤转移药物治疗的靶标及其应用 |
| MX2020012376A (es) | 2018-05-18 | 2021-03-09 | Incyte Corp | Derivados de pirimidina fusionados como inhibidores de los receptores de adenosina a2a/a2b. |
| MX2021000116A (es) | 2018-07-05 | 2021-03-29 | Incyte Corp | Derivados de pirazina fusionados como inhibidores de a2a/a2b. |
| TWI829857B (zh) | 2019-01-29 | 2024-01-21 | 美商英塞特公司 | 作為a2a / a2b抑制劑之吡唑并吡啶及三唑并吡啶 |
| WO2021168734A1 (zh) * | 2020-02-27 | 2021-09-02 | 世延生医股份有限公司 | 基质金属蛋白酶1的单克隆抗体、其检测试剂盒及其检测方法 |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003503354A (ja) | 1999-06-30 | 2003-01-28 | メルク エンド カムパニー インコーポレーテッド | Ｓｒｃキナーゼ阻害剤化合物 |
| CA2382919C (en) | 1999-10-08 | 2008-12-09 | Gruenenthal Gmbh | Bicyclic imidazo-3-yl-amine derivatives |
| HK1047748B (zh) | 1999-10-08 | 2004-10-21 | Grunenthal Gmbh | 在第六环上取代的二环咪唑并-3-基-胺的衍生物 |
| PT1218383E (pt) | 1999-10-08 | 2009-01-29 | Gruenenthal Gmbh | Derivados bicíclicos de imidazo-5-il-amina |
| DE10019714A1 (de) | 2000-04-20 | 2002-01-10 | Gruenenthal Gmbh | Salze von bicyclischen, N-acylierten Imidazo-3-aminen und Imidazo-5-aminen |
| NO311460B1 (no) | 2000-07-14 | 2001-11-26 | Zopa As | Fremgangsmåte og anordning for kjöling av produkter i et transportsystem |
| DE10050663A1 (de) | 2000-10-13 | 2002-04-18 | Gruenenthal Gmbh | Verwendung von substituierten Imidazo[1,2-a]pyridin-, -pyrimidin- und pyrazin-3-yl-amin-Derivaten zur Herstellung von Medikamenten zur NOS-Inhibierung |
| US20020132823A1 (en) | 2001-01-17 | 2002-09-19 | Jiahuai Han | Assay method |
| WO2002060492A1 (en) * | 2001-01-30 | 2002-08-08 | Cytopia Pty Ltd | Methods of inhibiting kinases |
| EP1509526A2 (en) * | 2002-04-19 | 2005-03-02 | Cellular Genomics Inc. | Imidazo(1,2-a)pyrazin-8-ylamines, method of making, and method of use thereof |
| WO2004026877A1 (en) * | 2002-09-23 | 2004-04-01 | Schering Corporation | Imidazopyrazines as cyclin dependent kinase inhibitors |
| WO2004037814A1 (en) | 2002-10-25 | 2004-05-06 | Vertex Pharmaceuticals Incorporated | Indazolinone compositions useful as kinase inhibitors |
| WO2004072080A1 (en) | 2003-02-10 | 2004-08-26 | Cellular Genomics, Inc. | Certain 8-heteroaryl-6-phenyl-imidazo[1,2-a]pyrazines as modulators of hsp90 complex activity |
| US7186832B2 (en) | 2003-02-20 | 2007-03-06 | Sugen Inc. | Use of 8-amino-aryl-substituted imidazopyrazines as kinase inhibitors |
| US7157460B2 (en) * | 2003-02-20 | 2007-01-02 | Sugen Inc. | Use of 8-amino-aryl-substituted imidazopyrazines as kinase inhibitors |
| WO2004092177A1 (en) | 2003-04-09 | 2004-10-28 | Biogen Idec Ma Inc. | Triazolopyrazines and methods of making and using the same |
| US7459554B2 (en) * | 2003-10-15 | 2008-12-02 | Osi Pharmaceuticals, Inc. | Imidazopyrazine tyrosine kinase inhibitors |
| WO2005085252A1 (en) | 2004-03-04 | 2005-09-15 | Biofocus Discovery Limited | Imidazo ‘1,2-a’ pyrazine compounds which interact with protein kinases |
| CA2570073A1 (en) | 2004-06-09 | 2005-12-22 | Oncalis Ag | Protein kinase inhibitors |
| CA2586259A1 (en) | 2004-11-08 | 2006-05-11 | Banyu Pharmaceutical Co., Ltd. | Novel fused imidazole derivative |
| KR20070119606A (ko) | 2004-11-10 | 2007-12-20 | 씨지아이 파마슈티칼스, 인크. | 특정 이미다조[１,２-ａ]피라진-８-일아민, 그의 제조 방법및 용도 |
| US20060149535A1 (en) * | 2004-12-30 | 2006-07-06 | Lg Electronics Inc. | Method for controlling speed of audio signals |
| WO2006086545A2 (en) | 2005-02-08 | 2006-08-17 | Robert W Desimone | Method to identify novel therapeutics |
| TW200716551A (en) | 2005-03-10 | 2007-05-01 | Cgi Pharmaceuticals Inc | Certain substituted amides, method of making, and method of use thereof |
| WO2007028051A2 (en) | 2005-09-02 | 2007-03-08 | Abbott Laboratories | Novel imidazo based heterocycles |
| TW200803863A (en) | 2005-11-10 | 2008-01-16 | Schering Corp | Method for inhibiting protein kinases |
| BRPI0618520A2 (pt) | 2005-11-10 | 2011-09-06 | Schering Corp | imidazopirazinas como inibidores de proteìna cinase |
| US7732609B2 (en) | 2005-12-01 | 2010-06-08 | Elan Pharmaceuticals, Inc. | 5-(arylsulfonyl)-pyrazolopiperidines |
| US7893058B2 (en) | 2006-05-15 | 2011-02-22 | Janssen Pharmaceutica Nv | Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases |
| WO2007138072A2 (en) * | 2006-05-31 | 2007-12-06 | Galapagos N.V. | Triazolopyrazine compounds useful for the treatment of degenerative & inflammatory diseases |
| US20100160292A1 (en) | 2006-09-11 | 2010-06-24 | Cgi Pharmaceuticals, Inc | Kinase Inhibitors, and Methods of Using and Identifying Kinase Inhibitors |
-
2007
- 2007-05-30 WO PCT/EP2007/055246 patent/WO2007138072A2/en not_active Ceased
- 2007-05-30 PT PT07729660T patent/PT2029602E/pt unknown
- 2007-05-30 CA CA002653506A patent/CA2653506A1/en not_active Abandoned
- 2007-05-30 MX MX2008015057A patent/MX2008015057A/es active IP Right Grant
- 2007-05-30 AT AT07729660T patent/ATE465164T1/de active
- 2007-05-30 US US11/809,294 patent/US7501411B2/en not_active Expired - Fee Related
- 2007-05-30 DK DK07729660.6T patent/DK2029602T3/da active
- 2007-05-30 EA EA200870592A patent/EA200870592A1/ru unknown
- 2007-05-30 KR KR1020087030751A patent/KR20090026288A/ko not_active Withdrawn
- 2007-05-30 AU AU2007267121A patent/AU2007267121A1/en not_active Abandoned
- 2007-05-30 NZ NZ573015A patent/NZ573015A/en not_active IP Right Cessation
- 2007-05-30 BR BRPI0712531-3A patent/BRPI0712531A2/pt not_active IP Right Cessation
- 2007-05-30 DE DE602007006010T patent/DE602007006010D1/de active Active
- 2007-05-30 JP JP2009512585A patent/JP2009538877A/ja not_active Abandoned
- 2007-05-30 HR HR20100378T patent/HRP20100378T1/hr unknown
-
2008
- 2008-10-30 IL IL195033A patent/IL195033A0/en unknown
- 2008-11-10 NO NO20084703A patent/NO20084703L/no not_active Application Discontinuation
- 2008-11-20 NI NI200800299A patent/NI200800299A/es unknown
- 2008-11-25 CR CR10458A patent/CR10458A/es unknown
- 2008-11-28 EC EC2008008923A patent/ECSP088923A/es unknown
-
2009
- 2009-03-08 US US12/399,979 patent/US7915256B2/en not_active Expired - Fee Related
-
2011
- 2011-01-09 US US12/987,129 patent/US20110178067A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009538877A5 (enExample) | ||
| HRP20100378T1 (hr) | Spojevi triazolopirazina učinkoviti za tretman degenerativnih i upalnih bolesti | |
| US8163759B2 (en) | Pyrazolo[1,5-A] pyrimidine compounds as CB1 receptor antagonist | |
| US9963462B2 (en) | Sepiapterin reductase inhibitors | |
| CA2878621C (en) | Pyrimidine pyrazolyl derivatives | |
| ES2461799T3 (es) | Derivados de indolil-piridona que tienen actividad inhibidora de la quinasa de control 1 | |
| US8461162B2 (en) | Pyrazolo[1,5-a]pyrimidine derivatives | |
| JP5323095B2 (ja) | ピロロ［２，３−ｄ］ピリミジンおよびそのチロシンキナーゼ阻害剤としての使用 | |
| US9662339B2 (en) | Benzodioxane inhibitors of leukotriene production for combination therapy | |
| JP2021506858A5 (enExample) | ||
| JP4846665B2 (ja) | ピラゾロ［１，５−ａ］ピリミジン化合物 | |
| JP2008530120A5 (enExample) | ||
| RU2014154397A (ru) | Соединения тетрагидропиразолопиримидина | |
| RU2007133655A (ru) | Замещенные бис-арильные и гетероарильные соединения в качестве селективных антагонистов 5нт2а | |
| JP2011518836A5 (enExample) | ||
| US20130029971A1 (en) | Cxcr3 receptor antagonists | |
| HRP20130958T1 (hr) | Supstituirani derivati sulfonamida | |
| RU2011111592A (ru) | Замещенные аминоинданы и их аналоги и их применение в фармацевтике | |
| CA2379575A1 (en) | Pharmaceutically active sulfonamide derivatives | |
| RU2007100136A (ru) | Соединения и композиции в качестве ингибиторов протеинкиназы | |
| RU2010118018A (ru) | Хиральные цис-имидазолины | |
| ES2411880T3 (es) | Usos terapéuticos de derivados de quinazolinodiona | |
| BR112012010820B1 (pt) | Compostos de octa-hidropirrolo[3,4-c]pirróis dissubstituídos, suas composições farmacêuticas e seu uso | |
| US20100267696A1 (en) | Amido-Thiophene Compounds and Their Use as 11-Beta-HSD1 Inhibitors | |
| CA3085333A1 (en) | Substituted indole ether compounds |